519
Views
16
CrossRef citations to date
0
Altmetric
Reviews

Current treatment options for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

Pages 188-198 | Received 21 Oct 2009, Accepted 26 Oct 2009, Published online: 09 Dec 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Francesca Musumeci, Silvia Schenone, Giancarlo Grossi, Chiara Brullo & Monica Sanna. (2015) Analogs, formulations and derivatives of imatinib: a patent review. Expert Opinion on Therapeutic Patents 25:12, pages 1411-1421.
Read now
Amanda J. Redig, Eliza Vakana & Leonidas C. Platanias. (2011) Regulation of mammalian target of rapamycin and mitogen activated protein kinase pathways by BCR–ABL. Leukemia & Lymphoma 52:sup1, pages 45-53.
Read now

Articles from other publishers (13)

Han-Seung Park. (2020) Current treatment strategies for Philadelphia chromosome-positive adult acute lymphoblastic leukemia. BLOOD RESEARCH 55:S1, pages S32-S36.
Crossref
Thomas Stübig & Nicolaus Kröger. 2020. Cancer Immunology. Cancer Immunology 119 133 .
Hayley Rose-Inman & Damon Kuehl. (2017) Acute Leukemia. Hematology/Oncology Clinics of North America 31:6, pages 1011-1028.
Crossref
Sung‐Nam Lim, Young‐Don Joo, Kyoo‐Hyung Lee, Dae‐Young Kim, Je‐Hwan Lee, Jung‐Hee Lee, Hyun‐Sook Chi, Sung‐Cheol Yun, Won Sik Lee, Sang Min Lee, Seonyang Park, Inho Kim, Sang Kyun Sohn, Joon Ho Moon, Hun‐Mo Ryoo, Sung Hwa Bae, Myung Soo Hyun, Min Kyoung Kim, Hyeoung Joon Kim, Deok‐Hwan Yang, Hyeon‐Seok Eom1, Gyeong‐Won Lee, Chul Won Jung, Jong‐Ho Won, Hawk Kim, Jae‐Hoon Lee, Ho‐Jin Shin & Dae‐Young Jang. (2015) Long‐term follow‐up of imatinib plus combination chemotherapy in patients with newly diagnosed P hiladelphia chromosome‐positive acute lymphoblastic leukemia . American Journal of Hematology 90:11, pages 1013-1020.
Crossref
Chuan Liu, Hongyu Ding, Xiaoxi Li, Christian P Pallasch, Liya Hong, Dianwu Guo, Yi Chen, Difei Wang, Wei Wang, Yajie Wang, Michael T Hemann & Hai Jiang. (2015) A DNA / HDAC dual‐targeting drug CY 190602 with significantly enhanced anticancer potency . EMBO Molecular Medicine 7:4, pages 438-449.
Crossref
Thomas Stübig & Nicolaus Kröger. 2015. Cancer Immunology. Cancer Immunology 105 116 .
Hayley Rose-Inman & Damon Kuehl. (2014) Acute Leukemia. Emergency Medicine Clinics of North America 32:3, pages 579-596.
Crossref
Xi Yang, Guangcui He, Yuping Gong, Bohui Zheng, Fangfang Shi, Rui Shi & Xiaojing Yang. (2014) Mammalian target of rapamycin inhibitor rapamycin enhances anti‐leukemia effect of imatinib on P h + acute lymphoblastic leukemia cells . European Journal of Haematology 92:2, pages 111-120.
Crossref
F Fei, H Abdel-Azim, M Lim, A Arutyunyan, M von Itzstein, J Groffen & N Heisterkamp. (2013) Galectin-3 in pre-B acute lymphoblastic leukemia. Leukemia 27:12, pages 2385-2388.
Crossref
Marilyn M. Li, April A. Ewton & Janice L. Smith. (2013) Using Cytogenetic Rearrangements for Cancer Prognosis and Treatment (Pharmacogenetics). Current Genetic Medicine Reports 1:2, pages 99-112.
Crossref
Alyssa Taylor & Carleen Van Siclen. (2013) A Rare Finding in Acute Lymphocytic Leukemia: Philadelphia Chromosome. Laboratory Medicine 44:2, pages e22-e24.
Crossref
Paul Farnsworth, David Ward & Vijay Reddy. (2012) Persistent complete molecular remission after nilotinib and graft-versus-leukemia effect in an acute lymphoblastic leukemia patient with cytogenetic relapse after allogeneic stem cell transplantation. Experimental Hematology & Oncology 1:1.
Crossref
Josep-Maria Ribera. (2011) Advances in acute lymphoblastic leukemia in adults. Current Opinion in Oncology 23:6, pages 692-699.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.